Intralesional Triamcinolone Acetonide Dosing for Scalp Alopecia Areata
For intralesional scalp steroid injections to treat alopecia areata, triamcinolone acetonide should be used at a concentration of 5-10 mg/mL, with 0.05-0.1 mL injected per site just beneath the dermis in the upper subcutis. 1, 2
Recommended Dosing Protocol
Concentration
- Triamcinolone acetonide: 5-10 mg/mL
- Both concentrations show similar efficacy and safety profiles 3
- Lower concentration (5 mg/mL) may be preferred to minimize side effects while maintaining efficacy
Administration Technique
- Injection depth: Just beneath the dermis in the upper subcutis
- Volume per injection site: 0.05-0.1 mL
- Coverage: Each injection produces a tuft of hair growth approximately 0.5 cm in diameter
- Multiple injections may be given, limited primarily by patient discomfort 1, 2
Treatment Schedule
Patient Selection
This treatment is most appropriate for:
- Patchy hair loss of limited extent
- Fewer than five patches of < 3 cm in diameter
- Cosmetically sensitive sites such as eyebrows 2
- Patients with less than 50% scalp involvement (traditional recommendation)
- However, can be effective in selected patients with more extensive involvement (50-99%) 5
Expected Outcomes
- 62% of patients achieve full regrowth with monthly injections 1, 2
- Response is better in patients with:
Monitoring
- Assess response after 6-12 weeks of treatment 4
- Dermoscopic evaluation can detect early response as soon as 4 weeks after initiating treatment 6
- Monitor for side effects at each visit
Potential Side Effects
- Skin atrophy at injection sites (most common)
- Mild pain during injection
- Folliculitis (can be minimized with proper technique)
- These side effects are typically reversible 5
Alternative Administration Methods
- Needleless devices (e.g., Dermajet) can be used as an alternative to traditional needle injection
Cautions
- Poor prognostic factors include:
- Childhood onset
- Ophiasis pattern
- Extensive hair loss
- Long disease duration
- Associated nail changes 4
- Recurrence rate is approximately 45% after 1-3 years 3
Intralesional triamcinolone acetonide remains the first-line treatment for limited patchy alopecia areata, with a favorable efficacy and safety profile when administered according to these guidelines.